Clinical trial
Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating…
NCT00334672 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00334672 |
|---|---|
| Title | Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis |
| Official title | Hemophagocytic Lymphohistiocytosis |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nonneoplastic Condition |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, dexamethasone, etoposide, methotrexate, mycophenolate mofetil, therapeutic hydrocortisone, laboratory biomarker analysis and 2 more |
| Enrollment | 288 |
| Start date | Mar 1, 2006 |
| Primary completion | Nov 1, 2010 |
| First posted | Jun 8, 2006 |
| Last update posted | Sep 17, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: